Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Nishigaki

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Research|August 1, 1988
Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in miceT Manda, F Nishigaki, J Mori, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 15, 2004
Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritisK Magari, S Miyata, F Nishigaki, et al.
Circulatory Shock|October 1, 1994
Potentiation of the toxicity of tumor necrosis factor by tumors in miceF Nishigaki, K Miyayasu, S Tsujimoto, et al.
Anticancer Research|November 1, 1994
Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in miceF Nishigaki, K Miyayasu, S Tsujimoto, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1994
Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cellsI Kawamura, E Lacey, Y Tanaka, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 1, 1990
[Significance of histocompatibility tests]F Nishigaki, M Nozaki, A Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumorT Manda, F Nishigaki, S Mukumoto, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 21, 2001
FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritisS Sakuma, F Nishigaki, K Magari, et al.
International Immunopharmacology|May 19, 2001
Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitroS Sakuma, Y Kato, F Nishigaki, et al.
Anticancer Research|March 1, 1994
The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cellsI Kawamura, E Lacey, T Mizota, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Research|August 1, 1988
Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in miceT Manda, F Nishigaki, J Mori, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 15, 2004
Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritisK Magari, S Miyata, F Nishigaki, et al.
Circulatory Shock|October 1, 1994
Potentiation of the toxicity of tumor necrosis factor by tumors in miceF Nishigaki, K Miyayasu, S Tsujimoto, et al.
Anticancer Research|November 1, 1994
Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in miceF Nishigaki, K Miyayasu, S Tsujimoto, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1994
Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cellsI Kawamura, E Lacey, Y Tanaka, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 1, 1990
[Significance of histocompatibility tests]F Nishigaki, M Nozaki, A Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumorT Manda, F Nishigaki, S Mukumoto, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 21, 2001
FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritisS Sakuma, F Nishigaki, K Magari, et al.
International Immunopharmacology|May 19, 2001
Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitroS Sakuma, Y Kato, F Nishigaki, et al.
Anticancer Research|March 1, 1994
The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cellsI Kawamura, E Lacey, T Mizota, et al.
Pageof 4